Partnership to provide life science, healthcare and research
professionals with comprehensive RWD capturing approximately 80% of
the Brazilian population
LONDON, Nov. 2, 2020 /PRNewswire/ -- Clarivate
Plc (NYSE:CCC), a global leader in providing trusted
information and insights to accelerate the pace of innovation,
today announced the expansion of international real-world data
offerings through its partnership with Techtrials Pesquisa e
Tecnologia Ltda (Techtrials), the leading healthcare real-world
data (RWD) provider in Brazil. The
new partnership will provide customers with comprehensive RWD
capturing approximately 80% of the Brazilian population.
As part of the three-year partnership, Clarivate customers can
access the largest integrated real-world database in Brazil to address the most pressing questions
related to epidemiological, clinical and pharmacoeconomic outcomes.
The dataset features in-depth, clinically structured, anonymized
data of billions of records with more than 195 million patients in
the public and private market as well as claims, electronic medical
records, registry and lab data. The comprehensive Techtrials
real-world data paired with the expertise, information and insights
that power DRG healthcare products and services, will allow global
researchers to access, synthesize and analyze critical data.
The Techtrials dataset will be available to life sciences
companies internationally, supporting a multitude of end users, to
enable deeper insights and delivery of complex and high value use
cases. Clients can choose from an array of delivery options
depending on their resource needs and expertise, including:
commercial targeting; patient population & market sizing;
patient journey; therapeutic area assessments; disease burden
analysis; health economics and outcomes research and more.
As the world's 11th largest pharmaceutical market, Brazil spends 9.5 percent of GDP on healthcare
– providing universal healthcare to its population.1
Multinational pharmaceutical companies continue to invest and
expand operations in Brazil, with
market researchers anticipating spending to increase at a compound
annual growth rate of 7% to 10% from 2018–2022.2
Clarivate recognizes the ever-increasing need for customers within
the Latin American market to have insights-ready RWD on a real-time
basis to help drive and inform decision-making.
Ken McLaren, SVP & GM of
Data, Analytics and Insights for Clarivate, said: "We appreciate
the complexity of healthcare and the diversity of decisions its
leaders must make, especially in an international context. We look
forward to partnering with an organization like Techtrials to help
our customers understand and drive decision-making with confidence
in the high growth, high interest Brazilian market."
Douglas Andreas Valverde, CEO,
Techtrials, said: "As a regional innovation leader for data
solutions and real-world evidence, we offer a unique mix of
capabilities and proprietary technology, providing valuable
clinical and real-world evidence insights to support the efforts of
pharmaceutical, healthcare and government agencies. We are proud to
partner with Clarivate to reach international industry stakeholders
who need to act and make critical decisions in their daily
operations."
The Brazilian RWD offering features insights, including: new
professionals per institution; variation of patients per period;
procedures; workload by institution; comprehensive disease,
epidemiology and market knowledge; drug use by specialty; outcomes,
hospitalizations, surgeries and sub-procedures; hospital and
comorbidities and more. The incorporation of Techtrials data
further reinforces the expertise provided by Clarivate to support
customers across the entire drug, device and medical technology
lifecycles.
To learn more, visit
https://clarivate.com/drg/real-world-data.
About Clarivate
Clarivate™ is a global leader in
providing solutions to accelerate the lifecycle of innovation. Our
bold mission is to help customers solve some of the world's most
complex problems by providing actionable information and insights
that reduce the time from new ideas to life-changing inventions in
the areas of science and intellectual property. We help customers
discover, protect and commercialize their inventions using our
trusted subscription and technology-based solutions coupled with
deep domain expertise. For more information, please
visit clarivate.com.
Media Contact
Catherine
Daniel
media.enquiries@clarivate.com
1National Health Account (NHA) Indicators 2020.
Source: Global Health Expenditure Database (GHED) of the World
Health Organization.
2"Brazil:
Commercialization Outlook, Global Market Access Solutions" 2020.
Source: DRG, part of Clarivate
View original content to download
multimedia:http://www.prnewswire.com/news-releases/clarivate-expands-international-real-world-data-offering-with-addition-of-techtrials-brazilian-dataset-301164471.html
SOURCE Clarivate Plc